XRAY

Barrington analyst Michael Petusky maintained a Buy rating on DENTSPLY SIRONA (XRAY - Research Report) today and set a price target of $40.00. The company's shares closed yesterday at $30.35.According to TipRanks, Petusky is a 4-star analyst with an average return of 7.0% and a 49.71% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Anika Therapeutics, Henry Schein, and Landec.In addition to Barrington, DENTSPLY SIRONA also received a Buy from Morgan Stanley's Erin Wright in a report issued yesterday. However, on the same day, Piper Sandler maintained a Hold rating on DENTSPLY SIRONA (NASDAQ: XRAY).
https://www.tipranks.com/news/blurbs/barrington-sticks-to-their-buy-rating-for-dentsply-sirona-xray?utm_source=advfn.com&utm_medium=referral